One Year Drug Treatment in First-Episode Schizophrenia
One Year Maintenance Treatment With Low Dose Haloperidol vs. Risperidone in First-Episode Schizophrenia
Sponsor: German Federal Ministry of Education and Research
This PHASE4 trial investigates Schizophrenia and is currently completed. German Federal Ministry of Education and Research leads this study, which shows 6 recorded versions since 2000 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Nov 2000
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- German Federal Ministry of Education and Research
- German Research Network On Schizophrenia
- Heinrich-Heine University, Duesseldorf
- Humboldt-Universität zu Berlin
- Janssen-Cilag Ltd.
- Mainz University
- Martin-Luther-Universität Halle-Wittenberg
- RWTH Aachen University
- University Hospital Tuebingen
- University of Bonn
- University of Cologne
- University of Göttingen
- University of Jena
- University of Mannheim
- University of München
- University of Wuerzburg
- Universität Duisburg-Essen
For direct contact, visit the study record on ClinicalTrials.gov .